Lindsey Strang, Associate
Axinn, Veltrop & Harkrider LLP
Lindsey Strang is an associate in Axinn’s antitrust group. Her practice focuses on civil litigation, government investigations, mergers and acquisitions, and counseling and compliance. Lindsey has recently been involved in litigating multiple class action lawsuits alleging price-fixing by major U.S. protein suppliers. Her recent antitrust work on strategic transactions includes Tyson Foods’ $1.2 billion sale of its pet treats business to General Mills. Lindsey maintains an active pro bono practice, and is currently leading an effort to recover owed wages from celebrity chef Mike Isabella and his business associates on behalf of a class of restaurant workers.
Marc Freedman, Senior Associate
Van Bael & Bellis
Marc Freedman is a Senior Associate in Van Bael and Bellis’ (VBB) newly-opened London office, focusing on UK and EU competition law.
Marc’s practice includes advising clients on complex UK, EU and multi-jurisdictional merger control, foreign direct investment screening, antitrust investigations, abuse of dominance, market studies and market investigations.
His experience spans numerous sectors, including financial services, tech and fintech, food and drink, automotive, basic industries, FMCG, pharmaceuticals and media.
Marc also recently completed a year-long secondment to the UK’s Competition and Markets Authority (CMA).
Dr. Fabian Leimgruber LL.M., Partner
Dr. Fabian Leimgruber is a lawyer and senior patent attorney, who has earned an international reputation as litigator and prosecutor mainly in the fields of competition and antitrust law, software and business methods patenting, pharmaceutical and life science IP protection. He practices in an advisory and forensic role as a licensed attorney before various courts on all levels, the Opposition and Appeal Boards of the European Patent Office, as well as national and international arbitration courts.
Juris Doctor in comparative antitrust and competition law. Natural Science Doctor in Physics. Specialized expertise in (i) competition/antitrust law, pharmaceutical industry and reverse payment settlement agreements, (ii) protection of software, business model and artificial intelligence, (iii) information technology (IT), electrical engineering and telecommunications, (iv) nano-technology and bio-chemistry.